Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 82

1.

Up-regulation of FOXO1 and reduced inflammation by β-hydroxybutyric acid are essential diet restriction benefits against liver injury.

Miyauchi T, Uchida Y, Kadono K, Hirao H, Kawasoe J, Watanabe T, Ueda S, Okajima H, Terajima H, Uemoto S.

Proc Natl Acad Sci U S A. 2019 Jul 2;116(27):13533-13542. doi: 10.1073/pnas.1820282116. Epub 2019 Jun 13.

2.

Effect of dietary antioxidant-rich foods combined with aerobic training on energy metabolism in healthy young men.

Takami M, Aoi W, Terajima H, Tanimura Y, Wada S, Higashi A.

J Clin Biochem Nutr. 2019 Jan;64(1):79-85. doi: 10.3164/jcbn.18-40. Epub 2018 Aug 8.

3.

A Prospective, Randomized Phase II Study of Adjuvant Gemcitabine Versus S-1 After Major Hepatectomy for Biliary Tract Cancer (KHBO 1208): Kansai Hepato-Biliary Oncology Group.

Kobayashi S, Nagano H, Tomokuni A, Gotoh K, Sakai D, Hatano E, Seo S, Terajima H, Uchida Y, Ajiki T, Satake H, Kamei K, Tohyama T, Hirose T, Ikai I, Morita S, Ioka T; Kansai Hepato-Biliary Oncology (KHBO) Group.

Ann Surg. 2019 Aug;270(2):230-237. doi: 10.1097/SLA.0000000000002865.

PMID:
30339627
4.

A-to-I RNA editing enzyme ADAR2 regulates light-induced circadian phase-shift.

Terajima H, Yoshitane H, Yoshikawa T, Shigeyoshi Y, Fukada Y.

Sci Rep. 2018 Oct 4;8(1):14848. doi: 10.1038/s41598-018-33114-6.

5.

Hepatectomy for gallbladder-cancer with unclassified anomaly of right-sided ligamentum teres: A case report and review of the literature.

Goto T, Terajima H, Yamamoto T, Uchida Y.

World J Hepatol. 2018 Jul 27;10(7):523-529. doi: 10.4254/wjh.v10.i7.523.

6.

Preventive Effect of Antioxidative Nutrient-Rich Enteral Diet Against Liver Ischemia and Reperfusion Injury.

Miyauchi T, Uchida Y, Kadono K, Hirao H, Kawasoe J, Watanabe T, Ueda S, Jobara K, Kaido T, Okajima H, Terajima H, Uemoto S.

JPEN J Parenter Enteral Nutr. 2019 Jan;43(1):133-144. doi: 10.1002/jpen.1308. Epub 2018 Jun 5.

PMID:
29870084
7.

Preoperative criterion identifying a low-risk group for lymph node metastasis in intrahepatic cholangiocarcinoma.

Yoh T, Hatano E, Seo S, Terajima H, Uchida Y, Taura K, Yasuchika K, Uemoto S.

J Hepatobiliary Pancreat Sci. 2018 Jun;25(6):299-307. doi: 10.1002/jhbp.552. Epub 2018 May 22.

PMID:
29656560
8.

Clinical impact of margin status on survival and recurrence pattern after curative-intent surgery for pancreatic cancer.

Yamamoto T, Uchida Y, Terajima H.

Asian J Surg. 2019 Jan;42(1):93-99. doi: 10.1016/j.asjsur.2017.09.003. Epub 2017 Dec 14.

9.

Ectopic Pancreatitis of the Jejunal Mesentery.

Yamakawa K, Kurita A, Terajima H, Yazumi S.

Intern Med. 2018 Mar 15;57(6):903-904. doi: 10.2169/internalmedicine.9548-17. Epub 2017 Nov 20. No abstract available.

10.

ADARB1 catalyzes circadian A-to-I editing and regulates RNA rhythm.

Terajima H, Yoshitane H, Ozaki H, Suzuki Y, Shimba S, Kuroda S, Iwasaki W, Fukada Y.

Nat Genet. 2017 Jan;49(1):146-151. doi: 10.1038/ng.3731. Epub 2016 Nov 28.

PMID:
27893733
11.

A case of neuroendocrine carcinoma in the hepatic hilar lymph nodes concomitant with an adenocarcinoma of the gallbladder.

Okada H, Uchida Y, Matsuzaki N, Goto T, Nishimura S, Kurita A, Nishimura T, Yazumi S, Terajima H.

World J Surg Oncol. 2016 Nov 14;14(1):284.

12.

Multi-institutional phase II study on the feasibility of liver resection following preoperative mFOLFOX6 therapy for resectable liver metastases from colorectal cancers.

Nagayama S, Hasegawa S, Hida K, Kawada K, Hatano E, Nakamura K, Seo S, Taura K, Yasuchika K, Matsuo T, Zaima M, Kanazawa A, Terajima H, Tada M, Adachi Y, Nishitai R, Manaka D, Yoshimura T, Doi K, Horimatsu T, Mitsuyoshi A, Yoshimura K, Niimi M, Matsumoto S, Sakai Y, Uemoto S.

Int J Clin Oncol. 2017 Apr;22(2):316-323. doi: 10.1007/s10147-016-1050-5. Epub 2016 Oct 17.

PMID:
27752787
13.

Questionnaire survey on work motivations of gastrointestinal and hepatobiliary pancreatic surgeons enrolled in a Japanese national interdisciplinary program.

Kaibori M, Nitta H, Hayashi M, Takemura S, Nagano H, Matsui K, Ikoma H, Nakai T, Yasunaga M, Kido M, Aoki T, Rikiyama T, Sano K, Kudo A, Katagiri S, Otsuka Y, Kuroki T, Nomi T, Yano K, Endo I, Ueno M, Kanazawa A, Terajima H, Ko S, Honda G, Seyama Y, Sunagawa H, Aibara T.

J Hepatobiliary Pancreat Sci. 2016 Nov;23(11):697-702. doi: 10.1002/jhbp.392. Epub 2016 Aug 30.

PMID:
27507645
14.

Thrombomodulin Attenuates Inflammatory Damage Due to Liver Ischemia and Reperfusion Injury in Mice in Toll-Like Receptor 4-Dependent Manner.

Kadono K, Uchida Y, Hirao H, Miyauchi T, Watanabe T, Iida T, Ueda S, Kanazawa A, Mori A, Okajima H, Terajima H, Uemoto S.

Am J Transplant. 2017 Jan;17(1):69-80. doi: 10.1111/ajt.13991. Epub 2016 Sep 14.

15.

Outcomes after resection of occupational cholangiocarcinoma.

Kubo S, Takemura S, Tanaka S, Shinkawa H, Kinoshita M, Hamano G, Ito T, Koda M, Aota T, Yamamoto T, Terajima H, Tachiyama G, Yamada T, Nakamori S, Arimoto A, Fujikawa M, Tomimaru Y, Sugawara Y, Nakagawa K, Unno M, Mizuguchi T, Takenaka K, Kimura K, Shirabe K, Saiura A, Uesaka K, Taniguchi H, Fukuda A, Chong JM, Kuwae Y, Ohsawa M, Sato Y, Nakanuma Y.

J Hepatobiliary Pancreat Sci. 2016 Sep;23(9):556-64. doi: 10.1002/jhbp.373. Epub 2016 Aug 1.

PMID:
27363864
16.

Preventive Measures for Postoperative Bile Leakage After Central Hepatectomy: A Multicenter, Prospective, Observational Study of 101 Patients.

Ishii T, Hatano E, Furuyama H, Manaka D, Terajima H, Uemoto S.

World J Surg. 2016 Jul;40(7):1720-8. doi: 10.1007/s00268-016-3453-x.

PMID:
26902629
17.

[CURRENT STATUS OF PERIOPERATIVE MANAGEMENT IN PATIENTS UNDERGOING ANTITHROMBOTIC (ANTIPLATELET OR ANTICOAGULATION) THERAPY: RESULTS OF A QUESTIONNAIRE SURVEY].

Fujikawa T, Yoshimura T, Terajima H, Manaka D, Okabe H, Tanaka A.

Nihon Geka Gakkai Zasshi. 2015 Sep;116(5):334-9. Japanese.

PMID:
26630745
18.

Pathological spectrum of bile duct lesions from chronic bile duct injury to invasive cholangiocarcinoma corresponding to bile duct imaging findings of occupational cholangiocarcinoma.

Kinoshita M, Kubo S, Nakanuma Y, Sato Y, Takemura S, Tanaka S, Hamano G, Ito T, Terajima H, Yamada T, Nakamori S, Arimoto A, Fujikawa M, Sugawara Y, Yamamoto T, Abue M, Nakagawa K, Unno M, Mizuguchi T, Takenaka K, Shirabe K, Shibata T.

J Hepatobiliary Pancreat Sci. 2016 Feb;23(2):92-101. doi: 10.1002/jhbp.305. Epub 2015 Dec 30.

PMID:
26580863
19.

The protective function of galectin-9 in liver ischemia and reperfusion injury in mice.

Hirao H, Uchida Y, Kadono K, Tanaka H, Niki T, Yamauchi A, Hata K, Watanabe T, Terajima H, Uemoto S.

Liver Transpl. 2015 Jul;21(7):969-81. doi: 10.1002/lt.24159.

20.

Conversion to complete resection with mFOLFOX6 with bevacizumab or cetuximab based on K-ras status for unresectable colorectal liver metastasis (BECK study).

Hatano E, Okuno M, Nakamura K, Ishii T, Seo S, Taura K, Yasuchika K, Yazawa T, Zaima M, Kanazawa A, Terajima H, Kaihara S, Adachi Y, Inoue N, Furumoto K, Manaka D, Tokka A, Furuyama H, Doi K, Hirose T, Horimatsu T, Hasegawa S, Matsumoto S, Sakai Y, Uemoto S.

J Hepatobiliary Pancreat Sci. 2015 Aug;22(8):634-45. doi: 10.1002/jhbp.254. Epub 2015 Apr 29.

PMID:
25926024
22.

[Hepatic resection for local recurrence after radiofrequency ablation therapy for colorectal liver metastases].

Iwamura S, Iida T, Terajima H, Matsubara H, Goto T, Inoue Y, Yoshitomi M, Uchida Y, Ueda S, Kanazawa A.

Gan To Kagaku Ryoho. 2014 Nov;41(12):2062-4. Japanese.

PMID:
25731423
23.

Education and imaging. Hepatology: pancreatic lymphoepithelial cyst mimicking mucinous cystic neoplasm.

Fujita K, Fujimoto M, Terajima H, Yazumi S.

J Gastroenterol Hepatol. 2015 Feb;30(2):235. doi: 10.1111/jgh.12829. No abstract available.

PMID:
25619236
24.

A multi-institution phase II study of gemcitabine/cisplatin/S-1 (GCS) combination chemotherapy for patients with advanced biliary tract cancer (KHBO 1002).

Kanai M, Hatano E, Kobayashi S, Fujiwara Y, Marubashi S, Miyamoto A, Shiomi H, Kubo S, Ikuta S, Yanagimoto H, Terajima H, Ikoma H, Sakai D, Kodama Y, Seo S, Morita S, Ajiki T, Nagano H, Ioka T.

Cancer Chemother Pharmacol. 2015 Feb;75(2):293-300. doi: 10.1007/s00280-014-2648-9. Epub 2014 Dec 5.

25.

[A case of locally advanced sigmoid colon cancer treated with neoadjuvant chemoradiotherapy].

Yoshitomi M, Hashida H, Nomura A, Ueda S, Terajima H, Osaki N.

Gan To Kagaku Ryoho. 2014 Sep;41(9):1175-8. Japanese.

PMID:
25248907
26.

Indication for neoadjuvant chemotherapy in patients with colorectal liver metastases based on a nomogram that predicts disease-free survival.

Okuno M, Hatano E, Seo S, Taura K, Yasuchika K, Nakajima A, Yazawa T, Furuyama H, Kawamoto H, Yagi S, Nishitai R, Fujikawa T, Arimoto A, Zaima M, Yoshimura T, Terajima H, Kaihara S, Manaka D, Tanaka A, Uemoto S.

J Hepatobiliary Pancreat Sci. 2014 Dec;21(12):881-8. doi: 10.1002/jhbp.149. Epub 2014 Aug 25.

PMID:
25155418
27.

Phase I study of adjuvant gemcitabine or S-1 in patients with biliary tract cancers undergoing major hepatectomy: KHBO1003 study.

Kobayashi S, Nagano H, Sakai D, Eguchi H, Hatano E, Kanai M, Seo S, Taura K, Fujiwara Y, Ajiki T, Takemura S, Kubo S, Yanagimoto H, Toyokawa H, Tsuji A, Terajima H, Morita S, Ioka T.

Cancer Chemother Pharmacol. 2014 Oct;74(4):699-709. doi: 10.1007/s00280-014-2543-4. Epub 2014 Jul 30.

PMID:
25074036
28.

The astaxanthin-induced improvement in lipid metabolism during exercise is mediated by a PGC-1α increase in skeletal muscle.

Liu PH, Aoi W, Takami M, Terajima H, Tanimura Y, Naito Y, Itoh Y, Yoshikawa T.

J Clin Biochem Nutr. 2014 Mar;54(2):86-9. doi: 10.3164/jcbn.13-110. Epub 2014 Feb 19.

29.

Phase I study of adjuvant chemotherapy with gemcitabine plus cisplatin in patients with biliary tract cancer undergoing curative resection without major hepatectomy (KHBO1004).

Toyoda M, Ajiki T, Fujiwara Y, Nagano H, Kobayashi S, Sakai D, Hatano E, Kanai M, Nakamori S, Miyamoto A, Tsuji A, Kaihara S, Ikoma H, Takemura S, Toyokawa H, Terajima H, Morita S, Ioka T.

Cancer Chemother Pharmacol. 2014 Jun;73(6):1295-301. doi: 10.1007/s00280-014-2431-y. Epub 2014 Mar 11.

30.

CLOCK-controlled polyphonic regulation of circadian rhythms through canonical and noncanonical E-boxes.

Yoshitane H, Ozaki H, Terajima H, Du NH, Suzuki Y, Fujimori T, Kosaka N, Shimba S, Sugano S, Takagi T, Iwasaki W, Fukada Y.

Mol Cell Biol. 2014 May;34(10):1776-87. doi: 10.1128/MCB.01465-13. Epub 2014 Mar 3.

31.

Case series of 17 patients with cholangiocarcinoma among young adult workers of a printing company in Japan.

Kubo S, Nakanuma Y, Takemura S, Sakata C, Urata Y, Nozawa A, Nishioka T, Kinoshita M, Hamano G, Terajima H, Tachiyama G, Matsumura Y, Yamada T, Tanaka H, Nakamori S, Arimoto A, Kawada N, Fujikawa M, Fujishima H, Sugawara Y, Tanaka S, Toyokawa H, Kuwae Y, Ohsawa M, Uehara S, Sato KK, Hayashi T, Endo G.

J Hepatobiliary Pancreat Sci. 2014 Jul;21(7):479-88. doi: 10.1002/jhbp.86. Epub 2014 Jan 13.

PMID:
24420816
32.

A biochemical landscape of A-to-I RNA editing in the human brain transcriptome.

Sakurai M, Ueda H, Yano T, Okada S, Terajima H, Mitsuyama T, Toyoda A, Fujiyama A, Kawabata H, Suzuki T.

Genome Res. 2014 Mar;24(3):522-34. doi: 10.1101/gr.162537.113. Epub 2014 Jan 9.

33.

Comparative outcomes of elderly and non-elderly patients receiving first-line palliative chemotherapy for advanced biliary tract cancer.

Kou T, Kanai M, Ikezawa K, Ajiki T, Tsukamoto T, Toyokawa H, Yazumi S, Terajima H, Furuyama H, Nagano H, Ikai I, Kuroda N, Awane M, Ochiai T, Takemura S, Miyamoto A, Kume M, Ogawa M, Takeda Y, Taira K, Ioka T.

J Gastroenterol Hepatol. 2014 Feb;29(2):403-8. doi: 10.1111/jgh.12338.

PMID:
23869919
34.

Effects of rikkunshito, a kampo medicine, on quality of life after proximal gastrectomy.

Gunji S, Ueda S, Yoshida M, Kanai M, Terajima H, Takabayashi A.

J Surg Res. 2013 Dec;185(2):575-80. doi: 10.1016/j.jss.2013.06.010. Epub 2013 Jun 28.

PMID:
23856127
35.

Patients with recurrent biliary tract cancer have a better prognosis than those with unresectable disease: retrospective analysis of a multi-institutional experience with patients of advanced biliary tract cancer who received palliative chemotherapy.

Ikezawa K, Kanai M, Ajiki T, Tsukamoto T, Toyokawa H, Terajima H, Furuyama H, Nagano H, Ikai I, Kuroda N, Awane M, Ochiai T, Takemura S, Miyamoto A, Kume M, Ogawa M, Takeda Y, Taira K, Ioka T.

J Hepatobiliary Pancreat Sci. 2014 Feb;21(2):98-104. doi: 10.1002/jhbp.2. Epub 2013 Jun 20.

PMID:
23798367
36.

[A case of lung metastases of carcinoma of the ampulla of vater effectively treated with S-1].

Hashida H, Inoue Y, Hattori K, Kadono K, Yoshimura M, Yoshida M, Abe S, Miyake M, Yoshitomi M, Nomura A, Ueda S, Terajima H, Osaki N.

Gan To Kagaku Ryoho. 2012 Apr;39(4):637-9. Japanese.

PMID:
22504692
37.

Single-particle tracking of quantum dot-conjugated prion proteins inside yeast cells.

Tsuji T, Kawai-Noma S, Pack CG, Terajima H, Yajima J, Nishizaka T, Kinjo M, Taguchi H.

Biochem Biophys Res Commun. 2011 Feb 25;405(4):638-43. doi: 10.1016/j.bbrc.2011.01.083. Epub 2011 Jan 28.

PMID:
21277285
38.

Surgical Therapy for a Solitary Form of Hepatic Epithelioid Hemangioendothelioma: A Long-Term Survival Case.

Oshima N, Terajima H, Hosotani R.

Case Rep Gastroenterol. 2009 Aug 28;3(2):214-221.

39.

Effectiveness of endoscopic nasobiliary drainage for postoperative bile leakage after hepatic resection.

Terajima H, Ikai I, Hatano E, Uesugi T, Yamamoto Y, Shimahara Y, Yamaoka Y.

World J Surg. 2004 Aug;28(8):782-6. Epub 2004 Aug 3.

PMID:
15457358
40.

Cholangitis and liver abscess after percutaneous ablation therapy for liver tumors: incidence and risk factors.

Shibata T, Yamamoto Y, Yamamoto N, Maetani Y, Shibata T, Ikai I, Terajima H, Hatano E, Kubo T, Itoh K, Hiraoka M.

J Vasc Interv Radiol. 2003 Dec;14(12):1535-42.

PMID:
14654488
41.

Resection for hepatocellular carcinoma with duodenal invasion: report of a case.

Hatano E, Ikai I, Shimizu M, Maetani Y, Konda Y, Chiba T, Terajima H, Yamamoto N, Yamamoto Y, Shimahara Y, Yamaoka Y.

Hepatogastroenterology. 2003 Jul-Aug;50(52):1034-6.

PMID:
12845974
42.

Suppressed complement activation in human decay accelerating factor transgenic porcine liver cross-circulated with nonhuman primates.

Matsushita T, Ikai I, Nishitai R, Katsura N, Yamanokuchi S, Matsuo K, Sugimoto S, Shiotani T, Takahashi R, Terajima H, Yamaoka Y.

Transplantation. 2003 Jun 15;75(11):1807-12.

PMID:
12811238
43.

Results of hepatic resection for hepatocellular carcinoma invading major portal and/or hepatic veins.

Ikai I, Yamamoto Y, Yamamoto N, Terajima H, Hatano E, Shimahara Y, Yamaoka Y.

Surg Oncol Clin N Am. 2003 Jan;12(1):65-75, ix.

PMID:
12735130
44.

Reduction of hepatic ischemia/reperfusion-induced injury by a specific ROCK/Rho kinase inhibitor Y-27632.

Ikeda F, Terajima H, Shimahara Y, Kondo T, Yamaoka Y.

J Surg Res. 2003 Feb;109(2):155-60.

PMID:
12643858
45.

Management of adrenal metastasis from hepatocellular carcinoma.

Momoi H, Shimahara Y, Terajima H, Iimuro Y, Yamamoto N, Yamamoto Y, Ikai I, Yamaoka Y.

Surg Today. 2002;32(12):1035-41.

PMID:
12541019
46.

Long-term culture of primary human hepatocytes with preservation of proliferative capacity and differentiated functions.

Katsura N, Ikai I, Mitaka T, Shiotani T, Yamanokuchi S, Sugimoto S, Kanazawa A, Terajima H, Mochizuki Y, Yamaoka Y.

J Surg Res. 2002 Jul;106(1):115-23.

PMID:
12127816
47.

Tumor thrombi in the portal vein system originating from gastrointestinal tract cancer.

Tanaka A, Takeda R, Mukaihara S, Hayakawa K, Takasu K, Terajima H, Yamaoka Y, Chiba T.

J Gastroenterol. 2002;37(3):220-8.

PMID:
11931537
48.

Significance of serum type IV collagen level of hepatectomized patients with chronic liver damage.

Shimahara Y, Yamamoto N, Uyama N, Okuyama H, Momoi H, Kamikawa T, Terajima H, Iimuro Y, Yamamoto Y, Ikai I, Kushihata F, Kiyochi H, Kobayashi N, Yamaoka Y.

World J Surg. 2002 Apr;26(4):451-6. Epub 2002 Feb 4.

PMID:
11910479
49.

[Resection and reconstruction of the inferior vena cava for major hepatic resection].

Terajima H, Yamaoka Y.

Nihon Geka Gakkai Zasshi. 2001 Nov;102(11):810-4. Japanese.

PMID:
11729647
50.

Influence of humoral immunoreaction on hepatic nonparenchymal cells in ex situ xenoperfused rat livers.

Uesugi T, Ikai I, Satoh S, Yagi T, Kanazawa A, Takeyama O, Nishitai R, Okabe H, Katsura N, Terajima H, Takahashi R, Yamaoka Y.

J Surg Res. 2001 Aug;99(2):272-81.

PMID:
11469897

Supplemental Content

Loading ...
Support Center